Defining aggressive prostate cancer using a 12-gene model
… a model of prostate cancer … a prostate cancer progression model using a quantitative analysis
of protein expression using immunohistochemistry on a TMA. This led to a 12-gene model …
of protein expression using immunohistochemistry on a TMA. This led to a 12-gene model …
Staging of prostate cancer
L Cheng, R Montironi, DG Bostwick… - …, 2012 - Wiley Online Library
… and a substaging system suitable for individualized care. … prostate cancer staging. The 2010
revision of the American Joint Committee on Cancer/Union Internationale Contre le Cancer (…
revision of the American Joint Committee on Cancer/Union Internationale Contre le Cancer (…
Transgenic models for prostate cancer research
NM Greenberg - Urologic Oncology: Seminars and Original …, 1996 - Elsevier
… vitro mouse model for prostate cancer. … Prostate cancer gene therapy: Herpes simplex virus
thymidine kinase gene transduction followed by ganciclovir in mouse prostatic cancer models…
thymidine kinase gene transduction followed by ganciclovir in mouse prostatic cancer models…
Mathematical modelling of prostate cancer growth and its application to hormone therapy
… After reviewing mathematical modelling of IAS for prostate cancer, we have presented a
stochastic model and shown that it is successful in reproducing statistical features of the time …
stochastic model and shown that it is successful in reproducing statistical features of the time …
Establishment of two human prostate cancer cell lines derived from a single bone metastasis.
NM Navone, M Olive, M Ozen, R Davis… - … Association for Cancer …, 1997 - AACR
… model systems of advanced prostate cancer. Our specific … were: (a to screen human prostate
cancer tissue samples derived … 30 tissue samples derived from primary prostate cancer of …
cancer tissue samples derived … 30 tissue samples derived from primary prostate cancer of …
Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer
Y Hirata, N Bruchovsky, K Aihara - Journal of theoretical biology, 2010 - Elsevier
… of a prostate cancer model with reversible and irreversible changes. In this model, the cancer
cells of … -linear model is sufficient for modelling prostate cancer subjected to IAS treatment. …
cells of … -linear model is sufficient for modelling prostate cancer subjected to IAS treatment. …
… of enzymatically active prostate‐specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models
… PSA produced by various human prostate cancer xenograft models have not been well …
prostate cancer models de®ne the least and the PC-82, the most, optimized xenograft model …
prostate cancer models de®ne the least and the PC-82, the most, optimized xenograft model …
Development of PIN and prostate adenocarcinoma cell lines: a model system for multistage tumor progression
CR Soares, MA Shibata, JE Green, CL Jorcyk - Neoplasia, 2002 - Elsevier
… Characterizations of PIN have generally been limited to histologic analysis because
there are few in vitro and in vivo model systems representing this stage of prostate cancer …
there are few in vitro and in vivo model systems representing this stage of prostate cancer …
Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer
GN Thalmann, PE Anezinis, SM Chang, HE Zhau… - Cancer research, 1994 - AACR
… prostate cancer model may permit, for the first time, the study of the molecular mechanisms
underlying human prostate cancer … PC-3 human prostate cancer cell line as a model, osseous …
underlying human prostate cancer … PC-3 human prostate cancer cell line as a model, osseous …
Neuroendocrine differentiation in prostate cancer: emerging biology, models, and therapies
L Puca, PJ Vlachostergios… - Cold Spring …, 2019 - perspectivesinmedicine.cshlp.org
… and the development of new model systems have provided new insights into mechanisms
driving treatment resistance in prostate cancer. Neuroendocrine prostate cancer is a complex …
driving treatment resistance in prostate cancer. Neuroendocrine prostate cancer is a complex …